The lack of Level 4 Biosafety labs (BSL-4) and standard research centres where detailed examinations on dangerous and emerging pathogens can be conducted, is making it impossible for Nigeria to partake in scientific research to develop vaccines for existing and emerging ailments, BusinessDay finding
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
